Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments. [PDF]
Müller S, Zeidler C, Ständer S.
europepmc +1 more source
Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series. [PDF]
Chakravadhanula U, Nagarajan M, Bhat S.
europepmc +1 more source
Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient. [PDF]
Valenzuela Godoy D +2 more
europepmc +1 more source
Comprehensive Transcriptomic Profiling of Nonatopic Prurigo Nodularis in Korean Patients Reveals Il-22-driven Epidermal Stress and Neuro-immuno-fibrotic Remodelling. [PDF]
Kim HS, Kim YS, Yosipovitch G.
europepmc +1 more source
The skin as a sentinel organ for neurodegeneration: An underrecognized target for dementia prevention. [PDF]
Han Y, Zhou C, Wang P, Karako K, Song P.
europepmc +1 more source
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis. [PDF]
Ständer S +8 more
europepmc +1 more source
Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials. [PDF]
Stander S +8 more
europepmc +1 more source
Clinical Trial Comparison of Dupilumab and Nemolizumab for Prurigo Nodularis FDA-Approved Biologic Therapy Selection in Prurigo Nodularis. [PDF]
Robertson A, Rohan C.
europepmc +1 more source

